Shopping Cart
- Remove All
Your shopping cart is currently empty
SB-612111 is a novel and potent human opiate receptor-like orphan receptor (ORL-1) antagonist with a high affinity for hORL-1 (Ki = 0.33 nM). It exhibits selectivity for μ-, κ-, and δ-receptors with Ki values of 57.6 nM, 160.5 nM, and 2109 nM, respectively. SB-612111 effectively antagonizes the pronociceptive action of Nociceptin in an acute pain model[1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $3,560 | 10-14 weeks | |
| 50 mg | $4,990 | 10-14 weeks | |
| 100 mg | $6,990 | 10-14 weeks |
| Description | SB-612111 is a novel and potent human opiate receptor-like orphan receptor (ORL-1) antagonist with a high affinity for hORL-1 (Ki = 0.33 nM). It exhibits selectivity for μ-, κ-, and δ-receptors with Ki values of 57.6 nM, 160.5 nM, and 2109 nM, respectively. SB-612111 effectively antagonizes the pronociceptive action of Nociceptin in an acute pain model[1]. |
| Targets&IC50 | μ opioid receptor:57.6 nM (Ki), κ opioid receptor:160.5 nM (Ki), δ opioid receptor:2109 nM (Ki), ORL1 (human):0.33 nM (Ki) |
| Molecular Weight | 418.40 |
| Formula | C24H29Cl2NO |
| Cas No. | 371980-98-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.